Immuno-fit study for patients on immunotherapy
Part of Cancer clinical trials.
This study looks at how well patients with solid tumors who are receiving immunotherapy (checkpoint inhibitors) can exercise. It aims to see if exercise testing can help track your health during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed solid tumor cancer.
- You are currently receiving or will receive checkpoint inhibitor drugs (like anti-PD-1, anti-PD-L1, or anti-CTLA-4) either after surgery or for advanced cancer.
- You are physically well enough to perform a cardiopulmonary exercise test (a test that measures your heart and lung function during exercise).
- You do not have serious heart, lung, or blood problems that would make the exercise test unsafe.
- You have not had prior immunotherapy for advanced cancer, unless it was after surgery and any side effects have resolved.
- If you previously received a checkpoint inhibitor, at least 6 months have passed since the last dose and your cancer has not returned.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well immunotherapy (a type of cancer treatment that helps your immune system attack cancer cells) works for people with various types of cancer. You may join if you are already planning to receive this treatment, and the study will track your outcomes to help improve future care.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This trial tests whether a supervised exercise program can help improve immune activity and treatment outcomes for people with non-small cell lung cancer who are already on immunotherapy. It is designed for people who are not currently very active.
This study looks at how your body responds to immunotherapy and how to manage side effects. It aims to separate the treatment's benefits from its unwanted reactions.
This study looks at whether physical activity can help reduce side effects from immunotherapy in people with melanoma. You may join if you are starting a certain type of immunotherapy for melanoma.
This study tests if adding a structured exercise program can help people with non-small cell lung cancer who are already on immunotherapy. It is for people who are not currently very active and are willing to travel to Dana-Farber Cancer Institute for some visits.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.